• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Cedar Nabs $102M to Modernize Patient Financial Experience

Share:

July 2, 2020

Cedar, a New York City-based healthcare financial engagement platform, today announced it has raised $102 million in Series C funding led by venture capital firm Andreessen Horowitz. The deal includes $77M in venture capital and $25M from JP Morgan in venture debt. The company also announced it has partnered with North Caroline-based health system Novant Health to deliver an innovative, personalized financial experience for Novant Health patients. Novant Health and Cedar expect to roll-out the new engagement and billing platform before the end of 2020.

Personalizing the Patient Financial Experience

Founded in 2016, Cedar is a healthcare financial engagement platform for hospitals, health systems, and medical groups that clarifies and simplifies the financial experience for patients, improving bill resolution and payment outcomes for providers. Using intuitive design and advanced data science, Cedar facilitates patient-centric financial engagement across the care journey.

Cedar’s platform uses EHR, demographic, external, and behavioral data to accommodate the needs of patients. Personalized experiences lead to better patient engagement and satisfaction, improving resolution and payment outcomes for providers.

Fuel the Next Phase of Cedar’s Growth

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

To support Cedar’s rapid growth, the latest round of funding will be used to invest in expanding the company’s reach and to accelerate product innovation and expansion. This past year, and even more so since the global COVID-19 pandemic, Cedar has expanded rapidly with innovative partnerships and collaborations with institutions like Novant Health, seeking to improve patient satisfaction and financial results, so they can continue to deliver the highest standards of care. Novant will roll out Cedar’s patient engagement and payment technology platform to modernize the payment experience for its patients across the network. Novant Health’s partnership with Cedar will also advance and accelerate key innovation initiatives that extend further into a pre-visit patient digital engagement.

“The COVID-19 pandemic has put a spotlight on many of the inefficiencies and archaic processes across our current healthcare system which has, in turn, driven an increase in the adoption of platforms like Cedar’s among healthcare providers,” said Florian Otto, CEO, and co-founder of Cedar. “Through this round of funding and our new partnership with Novant Health, Cedar’s patient engagement and payment technology platform will be able to offer an improved experience for more patients with simplified and personalized digital engagement strategies and payment support options. We’re very pleased with this strong show of support from our investors and partners and look forward to further enhancing our platform for patients and providers.”

Other participants in the fundraising round include Kaiser Permanente and individual angel investors including Jerod Mayo, linebacker coach for the New England Patriots and Jeff Vacirca, MD, FACP, and CEO of New York Cancer & Blood Specialists, as well as Cedar’s current investors including Kinnevik, Thrive Capital, Lakestar and Founders Fund. Andreessen Horowitz Managing Partner Scott Kupor will join Cedar’s board of directors. This round brings Cedar’s total capital raised to $157M to date.

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Global Pharmacovigilance Market Analysis Report and Forecasts 2020Global Pharmacovigilance Market Analysis Report and Forecasts 2020
  • Despite Industry Buzz, Femtech Funding Still LagsDespite Industry Buzz, Femtech Funding Still Lags
  • YourCoach Looks to Employer Space with New Version of Wellness PlatformYourCoach Looks to Employer Space with New Version of Wellness Platform
  • 7 Ways in Which Artificial Intelligence Will Change Healthcare7 Ways in Which Artificial Intelligence Will Change Healthcare
  • Forta Scores $55m to Scale Parent-led Autism Therapy PlatformForta Scores $55m to Scale Parent-led Autism Therapy Platform
  • Deepmind’s Health Team Makes The Jump To Google With Some NHS Partnerships In TowDeepmind’s Health Team Makes The Jump To Google With Some NHS Partnerships In Tow
  • Investment in New Healthcare Technology “Top Priority” for GCC RegionInvestment in New Healthcare Technology “Top Priority” for GCC Region
  • DocGo Reports Increased Revenue, Raises 2023 Revenue Guidance and More Digital Health EarningsDocGo Reports Increased Revenue, Raises 2023 Revenue Guidance and More Digital Health Earnings

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications